首頁 › 瀰漫性硬皮症 › 加州 › Los Angeles
Los Angeles, CA 的 瀰漫性硬皮症 臨床試驗
6 項針對 瀰漫性硬皮症 的研究正在 Los Angeles（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
招募中2 期
- UCLA, Los Angeles
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
招募中2 期
- University of California Los Angeles Scleroderma Center, Los Angeles
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
招募中3 期
- GSK Investigational Site, Los Angeles
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
招募中2/3 期
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
Platform Clinical Study for Conquering Scleroderma
招募中2 期
- Keck School of Medicine at USC Medical Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
招募中2 期
- Artiva Investigational Site Los Angeles, Los Angeles
其他城市的 瀰漫性硬皮症 試驗
- New York City, NY8 項研究
- Chicago, IL7 項研究
- Ann Arbor, MI7 項研究
- Durham, NC6 項研究
- Baltimore, MD5 項研究
- Houston, TX5 項研究
- Boston, MA5 項研究
- Pittsburgh, PA4 項研究
- Kansas City, KS4 項研究
- New Orleans, LA4 項研究
- Philadelphia, PA4 項研究
- Phoenix, AZ3 項研究
Los Angeles 的其他研究
- 非小細胞肺癌87 項研究
- 癌症（所有類型）73 項研究
- 乳癌72 項研究
- 前列腺癌61 項研究
- 大腸直腸癌59 項研究
- 轉移性癌症57 項研究
- 卵巢癌50 項研究
- 肺癌45 項研究
- 頭頸部鱗狀細胞癌42 項研究
- 胰臟癌36 項研究
- 子宮內膜癌34 項研究
- 黑色素瘤34 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月2日。各研究自行設定資格標準；由研究團隊決定參與者資格。